Literature DB >> 2764227

Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis.

M H Colley1, E Geppert, W A Franklin.   

Abstract

Abnormal proliferation of smooth muscle cells in pulmonary lymphangioleiomyomatosis (LAM) is thought to be influenced by estrogen and progesterone. However, the results of previous studies using cytosolic methods to measure estrogen and progesterone receptor content in lung tissue from these patients have been inconsistent. We used immunohistochemical methods to study the tissue distribution of estrogen and progesterone receptors in LAM as well as in smooth muscle of several other organs, including histologically normal lung, colon, bladder, prostate, uterus, and uterine leiomyomas. Progesterone receptor was expressed strongly and estrogen receptor more weakly by the abnormal myoid cells of LAM. Hormone receptors were absent from all other constituents of lung tissue in our patient. These findings were similar to those in histologically normal myometrium and uterine leiomyomas. Although we found focal labeling of prostatic stromal cells with anti-progesterone receptor, no other smooth muscle tissue expressed either estrogen or progesterone receptor. We conclude that LAM is an abnormal proliferation of smooth muscle cells that express both estrogen and progesterone receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764227     DOI: 10.1097/00000478-198909000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

Review 1.  Lymphangioleiomyomatosis.

Authors:  Francis X McCormack
Journal:  MedGenMed       Date:  2006-01-18

2.  Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.

Authors:  Yang Sun; Erik Zhang; Taotao Lao; Ana M Pereira; Chenggang Li; Li Xiong; Tasha Morrison; Kathleen J Haley; Xiaobo Zhou; Jane J Yu
Journal:  Horm Cancer       Date:  2014-07-29       Impact factor: 3.869

3.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 4.  Lymphangioleiomyomatosis and TSC2-/- cells.

Authors:  Thomas N Darling; Gustavo Pacheco-Rodriguez; Alfredo Gorio; Elena Lesma; Cheryl Walker; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

Review 5.  Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Authors:  Stephen C Juvet; Francis X McCormack; David J Kwiatkowski; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-10       Impact factor: 6.914

6.  Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

Authors:  Connie G Glasgow; Wendy K Steagall; Angelo Taveira-Dasilva; Gustavo Pacheco-Rodriguez; Xiong Cai; Souheil El-Chemaly; Marsha Moses; Thomas Darling; Joel Moss
Journal:  Respir Med       Date:  2010-07       Impact factor: 3.415

7.  Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.

Authors:  I Wahedna; S Cooper; J Williams; I C Paterson; J R Britton; A E Tattersfield
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

8.  Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.

Authors:  Roderic Espín; Alexandra Baiges; Eline Blommaert; Carmen Herranz; Antonio Roman; Berta Saez; Julio Ancochea; Claudia Valenzuela; Piedad Ussetti; Rosalía Laporta; José A Rodríguez-Portal; Coline H M van Moorsel; Joanne J van der Vis; Marian J R Quanjel; Anna Villar-Piqué; Daniela Diaz-Lucena; Franc Llorens; Álvaro Casanova; María Molina-Molina; Mireya Plass; Francesca Mateo; Joel Moss; Miquel Angel Pujana
Journal:  Mol Cancer Res       Date:  2021-07-26       Impact factor: 6.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.